1366358052560134145

Today we announced that results from the Phase 3 clinical trial of omidubicel will be presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation. #EBMT21 More here: https://t.co/QqgM4yG7zh

Send us a message